## **Core Concept**
Phase II clinical trials are a crucial part of the drug development process, primarily focused on assessing the efficacy and side effects of a drug in a larger population. These trials are conducted after initial safety has been confirmed in Phase I trials. The number of patients in Phase II trials can vary but generally ranges from 100 to 300.

## **Why the Correct Answer is Right**
The correct answer, **B. 100-300**, is right because Phase II clinical trials involve a larger group of patients than Phase I, aiming to gather preliminary data on whether the drug works in people who have a certain disease or condition. These trials are often randomized and may include a control group. The number of patients in this phase allows for meaningful statistical analysis of the drug's efficacy and side effect profile.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option suggests a range that is too small for Phase II trials, which typically involve more patients than Phase I to provide sufficient data on efficacy and side effects.
- **Option C:** This option suggests a range that overlaps with but is generally larger than what is typical for Phase II trials. Phase III trials usually involve larger numbers of patients.
- **Option D:** This option suggests an excessively large number of patients, more typical of Phase III or IV trials, which involve much larger populations to confirm efficacy and monitor side effects.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the progression from Phase I to Phase II trials is contingent upon the safety profile established in Phase I. Phase II trials are pivotal in determining the efficacy of a drug and guiding the design of larger Phase III trials. Understanding the purpose and typical patient numbers for each phase of clinical trials is crucial for any medical professional involved in clinical research.

## **Correct Answer:** B. 100-300.